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Enantiomeric and Diastereomeric Self-Assembled Multivalent 
(SAMul) Nanostructures ± Understanding the Effects of Chirality 
on Binding to Polyanionic Heparin and DNA 
Kiri A. Thornalley,[a] Erik Laurini,[b] Sabrina Pricl*b] and David K. Smith*[a] 
This paper is dedicated to the retirement of Prof Francois Diederich in honour of his pioneering work in physical organic 
supramolecular chemistry and the fields of stereoselective and biological molecular recognition. 
Abstract: A family of four self-assembling lipopeptides containing 
Ala-Lys peptides attached to a C16 aliphatic chain was synthesised.  
These compounds form two enantiomeric pairs that bear a 
diastereomeric relationship to one another (C16-L-Ala-L-Lys/C16-D-Ala-
D-Lys) and (C16-D-Ala-L-Lys/C16-L-Ala-D-Lys).  These diastereomeric 
pairs have very different critical micelle concentrations (CMCs), with 
LL/DD < DL/LD suggesting more effective assembly of the former.  
The self-assembled multivalent (SAMul) systems bind biological 
polyanions as result of the cationic lysine groups on their surfaces.  
Polyanion binding was investigated using dye displacement assays 
and isothermal calorimetry (ITC).  On heparin binding, there was no 
significant enantioselectivity, but there was a binding preference for 
the diastereomeric assemblies with lower CMCs.  Conversely, on 
DNA binding, there was a significant enantioselective preference for 
systems displaying D-lysine ligands, with a further slight preference 
for attachment to L-alanine, with the CMC being irrelevant.  Binding to 
adaptive, ill-defined heparin has a large favourable entropic term, 
suggesting it depends primarily on the cationic SAMul nanostructure 
maximising surface contact with heparin, which can adapt, displacing 
solvent and other ions.  Conversely, binding to well-defined, shape-
persistent DNA has a larger favourable enthalpic term, and combined 
with the enantioselectivity, this allows us to suggest that its binding is 
based on optimised individual electrostatic interactions at the 
molecular level, with a preference for binding to D-lysine.   
Polyanions are ubiquitous in biological systems and play vital 
roles in many processes ± both biological and medicinal. [1]  
Interestingly, given the plethora of anionic species in vivo, biology 
can nonetheless achieve effective control over anion-mediated 
processes.  DNA and heparin are archetypal charge dense 
polyanions, and given the intense biomedical interest in DNA for 
gene delivery[2] and heparin for coagulation control,[3] significant 
attention has focussed on binding them.[2-4]  However, only rarely 
have binding differences between them been probed.[5]  This is, 
in part, because these anions typically reside in different biological 
compartments, meaning that they rarely come into direct 
competition.  An exception to this is in bacterial biofilms where 
extracellular DNA is present and has been shown to compete with 
heparin for binding to the same proteins.[6]  Furthermore, in 
nanoscale therapeutics, a delivery vehicle for (e.g.) genetic 
material must transit the extracellular medium which is rich in 
heparin and other glycosaminoglycans ± polyanion competition 
for binding to synthetic systems therefore becomes important. 
One key strategy for polyanion binding employs cationic self-
assembled colloidal nanosystems,[7] indeed the general 
importance of colloidal systems in controlled molecular 
recognition events is increasingly recognised.[8] In cases where 
the self-assembled systems display specific ligands on the 
surfaces, and are capable of forming multivalent interactions[9] 
with the target, this can be classified as a self-assembled 
multivalent (SAMul) approach.[10] Considerable attention has 
focussed on the binding of DNA[2,11] or heparin[12] using SAMul 
ligand arrays.  Recently, we have begun to explore similarities and 
differences in their binding interactions.  It is well-known that 
different polyelectrolytes, such as heparin and DNA, have 
different persistence lengths, which can impact on their binding.[13]  
This has led us to introduce the simple descriptions of DNA as 
µshape-persistent¶, and heparin as µadaptive¶, to help explain 
differences in their multivalent interactions.[14]  
Given the importance of chirality in biomolecular 
recognition,[15] there has been some interest in exploring chiral 
preferences in polyanion binding.[16] We have reported that a 
chiral SAMul lysine ligand array can control polyanion binding.[17]  
Interestingly, however, when using lysine ligands, chiral 
recognition of heparin does not always occur ± Wang and 
Rabenstein reported that there was no impact of chirality in their 
peptide heparin binders,[18] whilst we found that the precise 
structure of the self-assembling system determined whether chiral 
recognition was achieved.[19]  In this new study we wanted to gain 
a more detailed understanding of the chiral preferences of both 
heparin and DNA, and unambiguously understand, in 
thermodynamic terms, any inherent differences in the way these 
important polyanions interact with chiral nanoscale objects. 
For this study, we designed a family of stereoisomeric 
lipopeptides capable of self-assembly ± C16-Ala-Lys (Fig. 1).  
These molecules each contain two chiral centres (Ala and Lys), 
and there are four possible stereoisomers overall ± two pairs of 
enantiomers with a diastereomeric relationship to each other: C16-
L-Ala-L-Lys and C16-D-Ala-D-Lys (LL and DD), as well as C16-D-
Ala-L-Lys and C16-L-Ala-D-Lys (DL and LD).  These lipopeptides 
should bind polyanions as a result of the cationic Lys unit with 
self-assembly enhancing binding via multivalency.  In contrast to 
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previous work,[17,19] the introduction of a second chiral centre (Ala) 
which does not directly participate at the binding interface allows 
us to probe both enantio- and diastereo-selectivity and gain much 
more detailed insight. 
Figure 1.  Family of four stereoisomeric self-assembling cationic lipopeptides 
studied here for their relative abilities to bind heparin and DNA.  There are two 
pairs of enantiomers (LL/DD & DL/LD) with a diastereomeric relationship. 
These molecules were synthesised in excellent yield and 
purity using standard peptide coupling and protecting group 
methodologies (see ESI).  Their NMR spectra were broadly 
similar to each other ± key proton resonances all appeared at 
equivalent ppm values. However, the coupling patterns, in 
particular for the CH2-N protons at ca. 3.1 ppm, were more 
complex for LL/DD than for DL/LD (see Fig. S24-S27, ESI). This 
reflects the diastereomeric relationship of these two pairs of 
compounds, leading to differences in 1H-1H coupling.  We propose 
this is induced by differences in conformational preferences 
between diastereoisomers, leading to changes in the torsion 
angles between coupled protons.  Circular Dichroism (CD) 
spectroscopy of the four compounds confirmed their existence as 
two enantiomeric pairs, with mirror image spectra.  However, 
there was a significant difference in peak maxima and ellipticities 
between diastereomeric LL/DD and DL/LD, supportive of 
conformational differences between diastereomers. 
Fig, 2 CD Spectra of LL/DD (left) and LD/DL (right) measured at a concentration 
of 2.27 mM in Tris-HCl (10 mM) and NaCl (150 mM), indicating significantly 
different profiles for each diastereomeric pair of enantiomers.  
Initially, we monitored self-assembly using Nile Red assays 
(Fig. S1-S4) and isothermal titration calorimetry (ITC, Fig. S21).  
Both methods gave critical micelle concentrations (CMCs) in 
excellent agreement (Table 1).  The enantiomers assembled 
identically into nanostructures that have equal and opposite 
chiralities as demonstrated by CD (recorded above the CMC). 
However, diastereomeric systems had very different self-
assembly properties.  Specifically, LL and DD have much lower 
CMCs (ca. 50 PM) than DL and LD (ca. 160 PM).  This 
corresponds to a significant difference in the free energy of 
micellisation ('Gmic) ± ca. 3 kJmol-1.  Interrogating the 
thermodynamics in more detail indicated that, as is often 
observed for hydrophobic self-assembly of ionic surfactants,[20] 
micellisation is entropically driven and slightly enthalpically 
disfavoured.  The self-assembly of LL and DD is slightly 
enthalpically preferred over DL and LD (1.0-1.5 kJmol-1) and 
slightly entropically preferred (1.5-2.0 kJmol-1).  In this way, the 
self-assembly of LL and DD is both enthalpically and entropically 
preferred over diastereomeric DL and LD.   
Table 1.  Critical Micelle Concentrations (CMCs, PM) determined by Nile Red 
assay (CMCNR) and isothermal calorimetry (CMCITC) and thermodynamic data, 
'Gmic, 'Hmic and T'Smic (in kJmol-1) extracted from ITC. 
 CMCNR CMCITC 'Gmic 'Hmic T'Smic 
LL 50 ±3 52 -24.5 3.2 27.7 
DD 43 ±3 48 -24.7 3.3 28.0 
DL 155 ±3 159 -21.7 4.3 26.0 
LD 166 ±3 172 -21.5 4.8 26.3 
 
Table 2.  Data from DLS measurements at a concentration of 1.14 mM to 
determine the average diameter (nm) from the volume distribution and the zeta 
potential (mV) of the self-assembled nanostructures. Results are reported as 
mean ± standard deviation of three experiments. 
 Diameter / nm Zeta Potential  /mV 
LL 6.49 ± 2.90 35.5 ± 3.3 
DD 7.17 ± 2.20 39.2 ± 2.2 
DL 9.17 ± 2.75 46.8 ± 0.5 
LD 8.60 ± 1.62 43.3 ± 0.6 
 
The self-assembled nanostructures were also characterised 
using dynamic light scattering (DLS, Fig. S5-S12).  In the intensity 
distribution for each of these self-assembling systems, two types 
of nanoscale object were observed, one with smaller diameter 
(<10 nm) and one with a larger diameter (ca. 100-300 nm).  For 
DL/LD the larger assemblies were more significant in the DLS 
analysis than for LL/DD (see ESI).  However, when corrected for 
the number of assemblies using the volume distribution, it was 
clear in all cases that the smaller micellar objects dominated the 
distribution (see ESI).  Transmission electron microscopy (TEM) 
analysis supported this view, with small micellar objects being 
mainly observed (Fig. S18).  Table 2 indicates that the 
diastereomers form different assemblies, with LL and DD 
assembling into smaller, better-defined micelles than DL/LD.  This 
would fit with the observation that LL/DD have lower CMCs.  The 
difference in assembly is supported by differences in the Nile Red 
assay data, which show a smaller fluorescence increase for Nile 
Red in the case of DL/LD than for LL/DD (Fig. S1-S4), indicative 
of a less well-organised hydrophobic domain in the former.   
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Interestingly, however, zeta potentials indicated that DL/LD have 
somewhat greater surface charge than LL/DD (Table 2) and the 
larger CD signals would also suggest greater chiral organisation 
of ligands for DL/LD.  We suggest this may be a result of the larger 
micelles formed by DL/LD having less highly curved surfaces and 
hence more well-packed charged head groups. 
Taking into account these observations, we reasoned there 
were three possible factors that may influence polyanion binding: 
1. LL and DD self-assemble more effectively into SAMul 
nanostructures than DL and LD, and may therefore be 
better polyanion binders. 
2. DL and LD form SAMul nanostructures with higher 
surface charge potentials than LL and DD, and may 
therefore be better polyanion binders. 
3. Optimised molecular-scale interactions between the 
SAMul ligands and biological polyanions may control 
binding, giving rise to preferences for systems with a 
specific chirality. 
We initially probed heparin binding for these systems using 
both Mallard Blue (MalB) dye displacement assays[21] and ITC 
(see ESI for details).  From the MalB displacement assay (Fig. 
S13-S14), LL and DD were better able to displace the dye, with 
lower EC50 values, indicating they are better heparin binders than 
DL or LD (Table 3).  There was no significant difference between 
enantiomers, with LL§DD and DL§LD.  This is in agreement with 
some of the previous results from Wang and Rabenstein,[18] and 
ourselves[19] suggesting a lack of enantioselectivity in heparin 
binding with lysine ligands.  Interestingly, the observed EC50 
values suggest that in this assay, these compounds only bind 
heparin once they have achieved the CMC value (i.e., EC50  
CMC).  As such, we suggest that in this assay, heparin binding 
depends primarily on the ability of the compounds to self-
assemble into a multivalent array.  This assay was repeated in 
human serum and binding preferences were maintained with 
LL/DD > DL/LD, although the EC50 values were somewhat higher 
(Table S1, Fig. S15). TEM imaging in the presence of heparin 
proves that the micellar objects remain stable on binding (Fig. 
S19).[22]  
Table 3.  Heparin binding data.  EC50 values (PM) from MalB displacement assay 
report the concentration of SAMul nanosystem required to displace 50% of MalB 
from its complex with heparin.  Thermodynamic data for SAMul nanosystems 
binding to heparin, 'Gbind, 'Hbind and T'Sbind (in kJmol-1), are extracted from 
isothermal titration calorimetry. Results are expressed as mean ± standard 
deviation of three experiments. 
Heparin  EC50 (MalB) 'Gbind 'Hbind T'Sbind 
LL  125.5 ± 4.5 -31.0 ± 0.1 -13.4 ± 0.1 17.6 ± 0.2 
DD  110.0 ± 2.2 -30.8 ± 0.1 -13.6 ± 0.2 17.2 ± 0.1 
DL  145.7 ±12.0 -28.4 ± 0.2 -12.2 ± 0.1 16.2 ± 0.1 
LD  135.0 ± 6.5 -29.1 ± 0.3 -12.5 ± 0.1 16.6 ± 0.2 
 
ITC measurements confirmed these results (Table 3, Fig. 
S22). ITC was performed above the CMC value to avoid 
complications from the energetics of demicellisation. There were 
small differences between the binding free energies of LL/DD 
(average 'Gbind -30.9 kJmol-1) and DL/LD (average 'Gbind = -28.8 
kJmol-1) ± an enhancement of ca. 2 kJmol-1 for LL/DD.  ITC 
therefore also suggests that LL/DD, which more effectively form 
smaller micelles, are better heparin binders.  In all cases, binding 
is enthalpically favoured, as a result of high-affinity electrostatic 
interactions between the SAMul cation and polyanionic heparin, 
and entropically favoured, as a result of the release of water and 
ions from the charged surfaces.  The difference in binding free 
energy between LL/DD and DL/LD has both an enthalpic 
component (ca. 1 kJmol-1), and an entropic component (ca. 1 
kJmol-1). 
We then studied DNA binding to these SAMul systems, using 
Ethidium Bromide (EthBr) dye displacement assays,[23] and ITC ± 
the results were remarkably different to those observed for 
heparin (Table 4).  In the EthBr displacement assay (Fig. S16-
S17), the EC50 values were much lower than those observed for 
heparin binding.  However, these are competition assays, 
performed against dye complexes of different affinities, and at 
different concentrations, so conclusions comparing DNA and 
heparin binding using this approach must be drawn with caution 
± the ITC results discussed below provide the best assessment of 
binding strength.  Notably, however, the EC50 values for DNA 
binding are below the CMC values, which would suggest that 
binding can even occur in the absence of self-assembly.  Indeed, 
it is well-known that binding to polyanions can occur below the 
CMC, encouraging self-assembly in the process.[24]  Furthermore, 
the different stereoisomers behave very differently to the heparin 
binding experiments. Compounds DD and LD are better DNA 
binders than LL or DL.  This would suggest that compounds 
displaying D-lysine ligands are more effective DNA binders than 
those with L-lysine ligands ± an enantioselective effect.  This 
appears to be largely independent of the chirality of the alanine 
unit, although there is a smaller effect, which suggests those 
compounds with L-alanine units perform slightly better than those 
with D-alanine.  As such, compound LD (C16-L-Ala-D-Lys) is the 
best DNA binder in this assay.  TEM imaging in the presence of 
DNA demonstrates that the self-assembled micelles remain 
stable on binding (Fig. S20) 
Table 4.  DNA binding data.  EC50 values (PM) from EthBr displacement assay 
report the concentration of SAMul nanosystem required to displace 50% of 
EthBr from its complex with DNA.  Thermodynamic data for SAMul nanosystems 
binding to heparin, 'Gbind, 'Hbind and T'Sbind (in kJmol-1), are extracted from 
isothermal titration calorimetry. Results are expressed as mean ± standard 
deviation of three experiments. 
DNA EC50 (EthBr) 'Gbind 'Hbind T'Sbind 
LL 15.6 ± 2.1 -22.7 ± 0.2 -11.3 ± 0.2 11.4 ± 0.3 
DD  9.5 ±1.3 -26.7 ± 0.3 -15.2 ± 0.1 11.5 ± 0.2 
DL 18.8 ±1.2 -21.4 ± 0.2 -10.9 ± 0.2 10.5 ± 0.3 
LD  6.1 ±1.0 -27.1 ± 0.1 -15.4 ± 0.3 11.7 ± 0.1 
 
The results from ITC replicate these observations (Table 4, 
Fig. S23), with LD and DD being the best DNA binders (LD slightly 
better than DD), and LL/DL being worse DNA binders (LL slightly 
COMMUNICATION          
 
 
 
 
better than DL).  The difference in binding free energy ('Gbind) 
between the best binder (LD) and the worst binder (DL) is large: 
5.7 kJmol-1.  This is significantly larger than, the 2.6 kJmol-1 
difference in 'Gbind we observed previously for related systems 
with glycine instead of alanine units,[19] suggesting that chiral 
alanine units help preorganise the lysine ligands for 
enantioselective recognition.  More detailed thermodynamic 
analysis indicates that the difference between DNA binders is 
primarily a result of different enthalpies of binding ('Hbind differs 
by up to 4.5 kJmol-1).  
Comparing differences between heparin and DNA (Fig. 3), it 
is evident that heparin binds these SAMul systems with higher 
affinity ('Gbind = -28.4 to -31.0 kJmol-1) than DNA ('Gbind = -21.4 
to -27.1 kJmol-1).  This primarily arises from the larger entropic 
benefits of heparin binding (see discussion below). 
Figure 3. Summary of thermodynamic data extracted from ITC for binding of 
stereoisomeric SAMul nanosystems to heparin and DNA, indicating that binding 
is both enthalpically and entropically favoured.  The minor preference in heparin 
binding of LL/DD can be observed, as can the significant, enthalpically driven, 
preference in DNA binding of DD and LD.  'Gbind is shown in red, 'Hbind in gold 
and T'Sbind in blue. 
For DNA binding, there are larger binding enthalpies ('Hbind 
up to -15.4 kJmol-1 for DNA but just -13.6 kJmol-1 for heparin).  
Shape-persistent DNA is better able to optimise individual 
interactions for enthalpic gain as a result of its well-defined 
repetitive structure, but heparin has relatively poorly organised 
electrostatic interactions.  This optimisation of enthalpic 
interactions gives rise to the stereochemical preferences 
expressed by DNA, which appears to have a clear primary 
preference for D-lysine and a small secondary preference for L-
alanine.  DNA has a well-defined double helical structure, with 
regularly repeating phosphate groups down the rigid backbone of 
the structure.  Indeed, it is well-known that DNA can achieve 
highly selective interactions with cationic ligands.[25] This is in 
sharp contrast to heparin, which has a more disperse structure 
with relatively randomly organised anionic saccharides along its 
more flexible backbone.    
Heparin has much larger binding entropies (T'Sbind values up 
to 17.6 kJmol-1 for heparin but just 11.5 kJmol-1 for DNA).  
Adaptive heparin can reorganise to achieve greater surface 
contact with the SAMul nanosystem leading to desolvation, but 
shape-persistent DNA cannot wrap round the SAMul 
nanostructure as effectively to maximise surface contact.  We 
suggest that this adaptability explains why heparin prefers to bind 
to the SAMul systems based on LL/DD that are better able to 
assemble into well-defined small micelles.   
In conclusion, the structural chiral information programmed 
into these self-assembling systems therefore plays a key role in 
controlling their performance ± charge density alone is insufficient 
to explain biological polyanion binding.[26]  Firstly, chirality controls 
self-assembly, with LL/DD being thermodynamically preferred 
over DL/LD.  The binding of adaptive, ill-defined heparin is driven 
primarily by the ability of the SAMul systems to self-assemble, 
with heparin wrapping round the nanosystem but not forming 
highly optimised electrostatic interactions with it.  Conversely, the 
binding of well-defined, shape-persistent DNA is controlled by the 
molecular-scale information programmed into the SAMul ligand 
systems, with D-lysine ligands being strongly preferred for 
effective binding.  There is also a minor preference for L-alanine 
over D-alanine, suggesting this second amino acid can play a role 
in helping pre-organise the lysine ligands for optimal binding.  
Thermodynamic data support this hypothesis, and indicate that 
these SAMul systems bind heparin more strongly than DNA, 
primarily as a result of the entropic gain associated with adaptive 
binding and surface desolvation, while DNA binding is more 
enthalpically favoured, as a result of the ability of the shape-
persistent well-defined polyanion to optimise individual 
electrostatic interactions.  These differences in polyanion binding 
can be quite large ± for example the difference in free energy of 
binding between heparin and DNA (''Gbind) is 8.3 kJmol-1 for LL 
(the best heparin binder) but only 2.0 kJmol-1 for LD (the best DNA 
binder).  Changing just one chiral centre in the ligand therefore 
has a significant effect on this type of polyanion selectivity (6.3 
kJmol-1).  As such, a SAMul-based DNA delivery system based 
on LD would be much less adversely affected by the presence of 
heparin than one based on LL.  Given the key biological and 
medicinal roles of these polyanions, we suggest that 
understanding structural effects of chirality on their nanoscale 
binding is of general significance.   
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